Temozolomide induced differentiation of K562 leukemia cells is not mediated by gene hypomethylation
- 1 July 1989
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 38 (13) , 2069-2075
- https://doi.org/10.1016/0006-2952(89)90059-2
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Detection of specific sequences among DNA fragments separated by gel electrophoresisPublished by Elsevier ,2006
- Direct analysis of RNA in whole cell and cytoplasmic extracts by gel electrophoresisAnalytical Biochemistry, 1987
- Antitumour imidazotetrazines—XBiochemical Pharmacology, 1986
- A spectrophotometric method for measuring hemoglobin in erythroleukemic cells (K562).Journal of Histochemistry & Cytochemistry, 1981
- Cellular differentiation, cytidine analogs and DNA methylationPublished by Elsevier ,1980
- Use of restriction enzymes to study eukaryotic DNA methylationJournal of Molecular Biology, 1978
- MspI, an isoschizomer of HpaII which cleaves both unmethylated and methylated HpaII sitesNucleic Acids Research, 1978
- Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), An alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388)Biochemical Pharmacology, 1975
- Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosomeBlood, 1975
- Mechanism of action of 5-(3,3-dimethyl-1-triazeno)imidazole-4-caboxamide in mammalian cells in cultureBiochemical Pharmacology, 1972